POLYSORBATE 80 (HX2)TM IS IN COMPLIANCE WITH THE CHINESE PHARMACOPOEIA

POLYSORBATE 80 (HX2)TM IS IN COMPLIANCE WITH THE CHINESE PHARMACOPOEIA

We are pleased to inform you that we submitted a drug master file to CDE (Center for
Drug Evaluation, National Medical Products Administration) for our Polysorbate 80 (HX2)TM .
Polysorbate 80 (HX2)TM, which is our ultrapure polysorbate 80, is now in compliance with
the United States Pharmacopeia [USP], the European Pharmacopoeia [EP], the Japanese
Pharmacopoeia [JP], and the Chinese Pharmacopoeia [ChP for injection].
You can use Polysorbate 80 (HX2)TM for development of various pharmaceutical products
for the Chinese market.

[Americas]

NOF AMERICA CORPORATION
E-mail: info@nofamerica.com
Tel: NY Office: +1-914-681-9790
CA Office: +1-650-993-7375

[Europe]
NOF EUROPE GmbH
E-mail: info@nofeurope.com
Tel: +49-69-7706-100-0

[Asia Pacific, Japan]
NOF CORPORATION
DDS Development Division
E-mail: ddsinfo@nof.co.jp

[China]
NOF (Shanghai) Co. Ltd.
E-mail: info@nof.cn
Tel: +86-21-6210-1100